- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
886
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
886 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
2292 | JP¥2,737.00 | 1.5% | -16.9% | JP¥86.6b | JP¥3,030.00 | PE27.7x | E32.9% | 3.3% | Food, Beverage & Tobacco | ||
ALX | AU$4.83 | 2.5% | -16.4% | AU$7.0b | AU$5.31 | PE23.3x | E22.3% | 8.3% | Transportation | ||
CTT | AU$1.51 | 6.3% | -47.9% | AU$575.7m | AU$1.84 | PE55x | E32.0% | n/a | Retail | ||
6196 | JP¥3,655.00 | 1.5% | -24.2% | JP¥70.2b | JP¥5,900.00 | PE14.2x | E13.7% | 2.8% | Diversified Financials | ||
DATA | UK£1.88 | 0.3% | -4.3% | UK£1.5b | UK£2.74 | PE45.1x | E27.7% | 2.5% | Commercial Services | ||
MERUS | €3.71 | 15.9% | -8.2% | €28.5m | €4.00 | PS1.2x | E84.0% | n/a | Capital Goods | ||
688266 | CN¥63.53 | 2.5% | 20.0% | CN¥16.8b | CN¥79.00 | PS34.4x | E127.3% | n/a | Pharmaceuticals & Biotech | ||
PRGS | US$65.05 | -0.4% | 19.8% | US$2.8b | US$73.29 | PE33.8x | E24.5% | 0% | Software | ||
002413 | CN¥4.53 | 0.4% | -16.1% | CN¥5.9b | n/a | PS5x | E105.8% | 0% | Capital Goods | ||
SKC | NZ$1.45 | 2.8% | -20.3% | NZ$1.1b | NZ$1.85 | PS1.3x | E47.6% | 0% | Consumer Services | ||
BRCK | UK£0.64 | 1.9% | 1.0% | UK£204.0m | UK£0.97 | PE24.6x | E46.5% | 5.3% | Capital Goods | ||
4480 | JP¥3,835.00 | 0% | -12.8% | JP¥124.6b | JP¥5,675.00 | PE45.9x | E31.7% | n/a | Healthcare | ||
1928 | HK$20.65 | -3.7% | -9.6% | HK$167.1b | HK$26.09 | PE20.4x | E19.2% | 0% | Consumer Services | ||
CICN | CHF 60.00 | 7.9% | 20.5% | CHF 254.8m | CHF 79.35 | PE24.9x | E28.3% | 0% | Tech | ||
4680 | JP¥1,313.00 | -2.1% | 135.3% | JP¥354.7b | JP¥1,352.86 | PE21.4x | E10.9% | 1.2% | Consumer Services | ||
HANZA | SEK 76.70 | 2.0% | -10.1% | SEK 3.3b | SEK 81.88 | PE26.4x | E34.5% | 1.6% | Tech | ||
688526 | CN¥14.70 | 2.0% | -27.9% | CN¥6.8b | CN¥20.20 | PE22.8x | E24.3% | 2.9% | Pharmaceuticals & Biotech | ||
9250 | JP¥1,460.00 | 3.2% | -15.9% | JP¥2.0b | n/a | PS0.6x | E97.2% | n/a | Software | ||
SKS | AU$1.95 | 12.8% | 548.3% | AU$218.0m | AU$2.15 | PE32.9x | E24.8% | 0.5% | Capital Goods | ||
VGL | NZ$3.14 | 2.3% | 90.3% | NZ$746.3m | NZ$3.08 | PS5.2x | E47.8% | 0% | Software | ||
ABSO | SEK 259.00 | 1.6% | -35.3% | SEK 2.9b | SEK 402.00 | PE23.2x | E24.8% | 1.2% | Capital Goods | ||
LIAB | SEK 229.20 | 1.2% | 15.1% | SEK 17.7b | SEK 263.67 | PE26x | E28.5% | 2.4% | Capital Goods | ||
VIVA3 | R$19.25 | -3.6% | -43.8% | R$4.5b | R$32.76 | PE9.1x | E13.8% | 1.9% | Consumer Durables | ||
ODD | US$42.88 | -3.8% | -7.8% | US$2.5b | US$52.63 | PE24.2x | E18.5% | n/a | Household |